Qianfoshan Hospital: Lung Neoplasms trials

The registry lists 11 Lung Neoplasms studies with Qianfoshan Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 3Phase 3 2No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly PatientsEnrolling by invitationNCT06883136
• Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLCRecruitingNCT06125041Phase 2
• Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung CanceRecruitingNCT06043973Phase 3
• Low-dose Radiotherapy Combined With Conventional Fractionated Radiotherapy in Lung Cancer After Immunotherapy ResistanceRecruitingNCT05906329Not applicable
• First-Line Treatment for Advanced Non-squamous Non-Small-Cell Lung Cancer With Negative Driver Gene: a Single-center, Single-Arm TrialRecruitingNCT05648071Phase 3
• Patient's Whole Process Follow-up Management(HOPE-1)RecruitingNCT05339568
• Almonertinib Plus Microwave Ablation in Advanced Non-small Cell Lung CancerNot yet recruitingNCT04755738Phase 2
• Oxycodone in Combination With Parathoracic Nerve Block is Used for Postoperative Analgesia in Lung CancerStatus unknownNCT05742256Phase 1
• A Real-World Study of Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)Status unknownNCT05652712
• First-Line Treatment of Advanced Non-Small-Cell Lung Cancer With Negative Driver Gene: a Multicenter, Single-Arm TrialStatus unknownNCT05574998Phase 2
• Efficacy and Safety Study of Medical Thoracoscope Cryotherapy Combined Standard First-line Treatment of Advanced Non-small Cell Lung Cancer and Malignant Pleural EffusionStatus unknownNCT05291403Not applicable